A cluster-randomized trial of benchmarking and multimodal quality improvement to improve rates of survival free of bronchopulmonary dysplasia for infants with birth weights of less than 1250 grams

Pediatrics

Volumn 119, Issue 5, 2007, Pages 876-890

  Walsh, Michele ^a   Laptook, Abbott ^b   Kazzi, S Nadya ^c   Engle, William A ^d   Yao, Qing ^e   Rasmussen, Maynard ^f   Buchter, Susie ^g   Heldt, Gregory ^f   Rhine, William ^h   Higgins, Rose ⁱ   Poole, Kenneth ^e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY   (United States)

^e RTI INTERNATIONAL   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Bronchopulmonary dysplasia; Quality improvement; Randomized trial

Indexed keywords

ALARM MONITOR; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; NEWBORN CARE; OXYGEN SATURATION; OXYGEN SUPPLY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

ADULT; BENCHMARKING; BRONCHOPULMONARY DYSPLASIA; CLUSTER ANALYSIS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; MALE; PREGNANCY; SURVIVAL RATE;

EID: 34248141166     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-2656     Document Type: Article

References (55)

1. Institute of Medicine, Committee on Quality of Health Care in America. To Err Is Human: Building a Safer Health System. Washington, DC: National Academies Press; 2000
2. Institute of Medicine, Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press; 2001
3. Institute of Medicine, Committee on the Health Professions Education Summit. Health Professions Education: A Bridge to Quality. Washington, DC: National Academies Press; 2003
4. Shojania KV, Ranji SR, McDonald JM, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control. JAMA. 2006;296:427-440
5. Lemons JA, Oh W, Korones SB, et al. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 to December 1996. Pediatrics. 2001;107(1). Available at: www.pediatrics.org/cgi/content/full/107/1/e1
6. Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet. 2006;367:1421-1431
7. Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics. 2000; 105:1216-1226
8. Furman L, Borowoski CE, Aucott S, Hack M. Hospitalization as a measure of morbidity among very low birth weight infants with chronic lung disease. J Pediatr. 1996;128:447-452
9. Kennedy KA, Verter J, Tyson JE, et al. Center differences in survival without chronic lung disease (CLD) in very-low-birthweight (VLBW) infants are not explained by population differences, or the presence and early management of respiratory distress syndrome (RDS). Pediatr Res. 1997;40:256A
10. Vohr BR, Wright LL, Dusick AM, et al. Center differences and outcomes of extremely low birth weight infants. Pediatrics. 2004;113:781-789
11. Van Marter LJ Allred EN, Pagano M, et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics. 2001;105: 1194-1201
12. Plesk P. Innovative thinking for the improvement of medical systems. Ann Intern Med. 1999;131:438-444
13. Walsh M, Yao Q, Gettner P, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004;114:1305-1311
14. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723-1729
15. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92:529-534
16. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984;102:1130-1134
17. Walsh MC, Kliegman R. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986;33:179-201
18. Richardson DK, Corcoran JD, Escobar GJ, Lee SK. SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr. 2001;138:92-100
19. Zeger SL, Liang KY. An overview of methods for the analysis of longitudinal data. Stat Med. 1992;11:1825-1839
20. Gail MH, Byar DP, Pechacek TF, Corle DK. Aspects of statistical design for the Community Intervention Trial for Smoking Cessation (COMMIT). Control Clin Trials. 1992;13:6-21
21. Horbar JD, Rogowski J, Plsek PE, et al. Collaborative quality improvement for neonatal intensive care. Pediatrics. 2001;107:14-22
22. Jobe AH, Ikegami IM. Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res. 2001;2:27-32
23. Albertine KH, Jones GP, Starcher BC, et al. Chronic lung injury in preterm lambs: disordered respiratory tract development. Am J Respir Crit Care Med. 1999;159:945-958
24. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med. 2003;349:959-967
25. Tremblay LV, Velena F, Ribeiro S, et al. Injurious ventilatory strategies increase cytokines and c-fos mRNA expression in an isolated rat lung model. J Clin Invest. 1997;99:944-952
26. Linder W, Vosbeck S, Hummler H, Pohlandt F. Delivery room management of extremely low birth weight infants: spontaneous breathing or intubation. Pediatrics. 1999;103:961-967
27. Aly HZ. Nasal prongs continuous positive airway pressure: a simple yet powerful tool. Pediatrics. 2001;108:759-761
28. Ikegami M, Jobe AH. Postnatal lung inflammation increased by ventilation of preterm lambs exposed antenatally to Escherichia coli endotoxin. Pediatr Res. 2002;52:356-362
29. Ferguson TB Jr, Peterson PE, Coombs LP, et al. Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery. JAMA. 2003;290:49-56
30. Mehta RH, Montoye CK, Gallogly M, et al. Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) Initiative. JAMA. 2002;287:1269-1276
31. Kiefe CI, Allison AJ, Williams OD, et al. Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA. 2001;285:2871-2879
32. Bradley EH, Herrin HJ, Mattera JA, et al. Quality improvement efforts and hospital performance: rates of β-blocker prescription after acute myocardial infarction. Med Care. 2005;43:282-292
33. Solberg LI, Kottke T, Brekke ML, et al. Failure of a continuous quality improvement intervention to increase the delivery of preventive services: a randomized trial. Eff Clin Pract. 2000;3:105-115
34. Goldberg HI, Wagner EH, Fihn SD, et al. A randomized controlled trial of CQI teams and academic detailing: can they alter compliance with guidelines? Jt Comm J Qual Improv. 1998;24:130-142
35. Landon BE, Wilson IB, McInnes K, et al. Effects of a quality improvement collaborative on the outcome of care of patients with HIV infection: the EQHIV Study. Ann Intern Med. 2004;140:887-896
36. Lozano P, Finkelstein JA, Carey VJ, et al. A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study. Arch Pediatr Adolesc Med. 2004;158:875-883
37. Payne NR, Finkelstein MJ, Chen S, et al. Reduction of chronic lung disease (CLD) among very low birth weight (VLBW) infants: experience of a Vermont Oxford Network (VON) quality improvement collaborative (NIC/Q 2002). E-PAS. 2005;57:134
38. Horbar JD, Carpenter J, Buzas J, et al. Collaborative quality improvement to promote evidence based surfactant for preterm infants: a cluster randomised trial. BMJ. 2004;329:1004-1010
39. Walsh M, Engle W, Laptook A, et al. Oxygen delivery through nasal cannulae to preterm infants: can practice be improved? Pediatrics. 2005;116:857-861
40. Goodman SN, Berlin JA. The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med. 1994;121:200-206
41. Detsky AS, Sackett DL. When was a "negative" clinical trial big enough? How many patients you needed depends on what you found. Arch Intern Med. 1985;145:709-712
42. Wachter RM. Expected and unanticipated consequences of the quality and information technology revolutions. JAMA. 2006;295:2780-2783
43. Han YY, Carcill JA, Venkatarman ST, et al. Unexpected increased mortality after implementation of a commercially sold computerized physician order entry system. Pediatrics. 2005;144:1506-1512
44. Nopper AJ, Hoii KA, Sookdeo-Drost S, et al. Topical ointment therapy benefits premature infants. J Pediatr. 1996;128:660-669
45. Edwards WH, Conner JM, Soll RF, et al. The effect of prophylactic ointment therapy on nosocomial sepsis rates and skin integrity in infants with birth weights of 501 to 1000 g. Pediatrics. 2004;113:1195-1203
46. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2001;(2):CD000510
47. Subramaniam P, Henderson-Smart DJ, Davis PG. Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev. 2005;(3):CD001243
48. Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2000;(2):CD001456
49. Woodgate PG, Davies MW. Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newborn infants. Cochrane Database Syst Rev. 2001;(2):CD002061
50. Askie LM, Henderson-Smart DJ. Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev. 2001;(4):CD001077
51. Woodgate PG, Flenady V. Tracheal suctioning without disconnection in intubated ventilated neonates. Cochrane Database Syst Rev. 2001;(2):CD003065
52. Ng E, Taddio A, Ohlsson A. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. Cochrane Database Syst Rev. 2003;(1):CD002052
53. Shortell SM, Zimmerman JE, Rousseau DM, et al The performance of intensive care units: does good management make a difference? Med Care. 1994;32:508-525
54. Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2001;(3):CD000503
55. McGuire W, Anthony MY. Formula milk versus preterm human milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev. 2001;(3):CD002972